CPRX logo

Catalyst Pharmaceuticals, Inc. (CPRX) Retained Earnings

Annual Retained Earnings:

$285.16M+$163.89M(+135.14%)
December 31, 2024

Summary

  • As of today, CPRX annual retained earnings is $285.16 million, with the most recent change of +$163.89 million (+135.14%) on December 31, 2024.
  • During the last 3 years, CPRX annual retained earnings has risen by +$311.47 million (+1183.85%).
  • CPRX annual retained earnings is now at all-time high.

Performance

CPRX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

Quarterly Retained Earnings:

$394.01M+$52.11M(+15.24%)
June 30, 2025

Summary

  • As of today, CPRX quarterly retained earnings is $394.01 million, with the most recent change of +$52.11 million (+15.24%) on June 30, 2025.
  • Over the past year, CPRX quarterly retained earnings has increased by +$208.66 million (+112.58%).
  • CPRX quarterly retained earnings is now at all-time high.

Performance

CPRX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

CPRX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+135.1%+112.6%
3Y3 Years+1183.8%+10000.0%
5Y5 Years+321.6%+463.2%

CPRX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+1183.8%at high+1515.4%
5Y5-Yearat high+321.6%at high+704.8%
All-TimeAll-Timeat high+277.6%at high+344.4%

CPRX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
$394.01M(+15.2%)
Mar 2025
-
$341.90M(+19.9%)
Dec 2024
$285.16M(+135.1%)
$285.16M(+24.4%)
Sep 2024
-
$229.22M(+23.7%)
Jun 2024
-
$185.34M(+28.2%)
Mar 2024
-
$144.55M(+19.2%)
Dec 2023
$121.27M(+143.2%)
$121.27M(+40.3%)
Sep 2023
-
$86.43M(-26.3%)
Jun 2023
-
$117.19M(+47.5%)
Mar 2023
-
$79.43M(+59.3%)
Dec 2022
$49.86M(+289.5%)
$49.86M(+104.4%)
Sep 2022
-
$24.39M(+1384.5%)
Jun 2022
-
$1.64M(+110.5%)
Mar 2022
-
-$15.62M(+40.6%)
Dec 2021
-$26.31M(+51.0%)
-$26.31M(+19.2%)
Sep 2021
-
-$32.54M(+14.0%)
Jun 2021
-
-$37.82M(+18.4%)
Mar 2021
-
-$46.34M(+13.7%)
Dec 2020
-$53.71M(+58.3%)
-$53.71M(+17.6%)
Sep 2020
-
-$65.14M(+40.0%)
Jun 2020
-
-$108.48M(+8.3%)
Mar 2020
-
-$118.26M(+8.1%)
Dec 2019
-$128.69M(+19.9%)
-$128.69M(+5.8%)
Sep 2019
-
-$136.62M(+9.1%)
Jun 2019
-
-$150.25M(+6.8%)
Mar 2019
-
-$161.21M(-0.4%)
Dec 2018
-$160.56M(-26.9%)
-$160.56M(-9.9%)
Sep 2018
-
-$146.06M(-5.7%)
Jun 2018
-
-$138.23M(-4.5%)
Mar 2018
-
-$132.26M(-4.5%)
Dec 2017
-$126.56M(-17.0%)
-$126.56M(-4.4%)
Sep 2017
-
-$121.17M(-3.6%)
Jun 2017
-
-$117.00M(-3.4%)
Mar 2017
-
-$113.12M(-4.6%)
Dec 2016
-$108.15M(-20.1%)
-$108.15M(-4.0%)
Sep 2016
-
-$103.98M(-4.0%)
Jun 2016
-
-$100.03M(-4.8%)
Mar 2016
-
-$95.46M(-6.0%)
Dec 2015
-$90.08M
-$90.08M(-6.9%)
DateAnnualQuarterly
Sep 2015
-
-$84.26M(-5.6%)
Jun 2015
-
-$79.81M(-6.1%)
Mar 2015
-
-$75.25M(-7.7%)
Dec 2014
-$69.84M(-28.5%)
-$69.84M(-5.3%)
Sep 2014
-
-$66.35M(-8.2%)
Jun 2014
-
-$61.34M(-5.5%)
Mar 2014
-
-$58.14M(-7.0%)
Dec 2013
-$54.33M(-28.8%)
-$54.33M(-2.6%)
Sep 2013
-
-$52.98M(-12.6%)
Jun 2013
-
-$47.07M(-7.2%)
Mar 2013
-
-$43.92M(-4.1%)
Dec 2012
-$42.18M(-10.7%)
-$42.18M(-0.2%)
Sep 2012
-
-$42.10M(-6.6%)
Jun 2012
-
-$39.48M(-0.7%)
Mar 2012
-
-$39.19M(-2.9%)
Dec 2011
-$38.10M(-20.2%)
-$38.10M(-6.6%)
Sep 2011
-
-$35.75M(-3.3%)
Jun 2011
-
-$34.62M(-4.2%)
Mar 2011
-
-$33.23M(-4.8%)
Dec 2010
-$31.71M(-14.5%)
-$31.71M(-2.4%)
Sep 2010
-
-$30.98M(-3.0%)
Jun 2010
-
-$30.08M(-4.6%)
Mar 2010
-
-$28.75M(-3.8%)
Dec 2009
-$27.71M(-35.4%)
-$27.71M(-4.4%)
Sep 2009
-
-$26.54M(-5.1%)
Jun 2009
-
-$25.26M(-7.5%)
Mar 2009
-
-$23.49M(-14.8%)
Dec 2008
-$20.46M(-106.7%)
-$20.46M(-22.4%)
Sep 2008
-
-$16.72M(-20.6%)
Jun 2008
-
-$13.86M(-20.7%)
Mar 2008
-
-$11.48M(-16.0%)
Dec 2007
-$9.90M(-71.9%)
-$9.90M(-10.6%)
Sep 2007
-
-$8.95M(-8.9%)
Jun 2007
-
-$8.22M(-17.2%)
Mar 2007
-
-$7.01M(-21.7%)
Dec 2006
-$5.76M(-90.1%)
-$5.76M(-14.8%)
Sep 2006
-
-$5.02M(-35.7%)
Jun 2006
-
-$3.70M(-22.0%)
Dec 2005
-$3.03M(-147.5%)
-$3.03M(-147.5%)
Dec 2004
-$1.22M
-$1.22M

FAQ

  • What is Catalyst Pharmaceuticals, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. annual retained earnings year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

What is Catalyst Pharmaceuticals, Inc. annual retained earnings?

The current annual retained earnings of CPRX is $285.16M

What is the all-time high annual retained earnings for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high annual retained earnings is $285.16M

What is Catalyst Pharmaceuticals, Inc. annual retained earnings year-on-year change?

Over the past year, CPRX annual retained earnings has changed by +$163.89M (+135.14%)

What is Catalyst Pharmaceuticals, Inc. quarterly retained earnings?

The current quarterly retained earnings of CPRX is $394.01M

What is the all-time high quarterly retained earnings for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high quarterly retained earnings is $394.01M

What is Catalyst Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

Over the past year, CPRX quarterly retained earnings has changed by +$208.66M (+112.58%)
On this page